Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$59K Sell
12,625
-7,169
-36% -$40.4K ﹤0.01% 1328
2025
Q4
$105K Buy
19,794
+1,855
+10% +$8.31K ﹤0.01% 1320
2025
Q3
$83K Buy
+17,939
New +$72.2K ﹤0.01% 1330

Other funds holding RERE

VanEck Associates's RERE Position: Q1 2026 in Review

VanEck Associates reduced its ATRenew (RERE) stake by 36% in Q1 2026, selling an estimated $40.4K and leaving 12,625 shares worth $59K. The position accounts for ﹤0.01% of the portfolio, ranked #1328.

VanEck Associates first reported a position in RERE in Q3 2025 and has held it in 3 quarters since. The position peaked at $105K in Q4 2025. 82 funds tracked by Wall St. Rank hold RERE as of Q1 2026.

  • VanEck Associates held 12,625 shares of ATRenew worth $59K as of Q1 2026.
  • VanEck Associates sold 7,169 ATRenew shares in Q1 2026, an estimated $40.4K.
  • ATRenew made up ﹤0.01% of VanEck Associates's portfolio in Q1 2026, its #1328 holding.
  • VanEck Associates first reported a position in ATRenew in Q3 2025 and has held it in 3 quarters since.
  • VanEck Associates's ATRenew position peaked at $105K in Q4 2025.
  • 82 funds tracked by Wall St. Rank held ATRenew as of Q1 2026.

Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.